Recombinant Activated Factor VIIa Treatment for Refractory Hemorrhage in Infants

OBJECTIVE: Report clinical response to recombinant factor VIIa in a cohort of critically ill infants. STUDY DESIGN: We identified all infants who received factor VIIa in the Duke Neonatal Intensive Care Unit between January 2005 and July 2008. Hematologic data and volume of blood transfusions before...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Dang, Chi N, Katakam, Lakshmi I, Smith, P Brian, Cotten, C Michael, Goldberg, Ronald N, Chandler, Nicole, Thornburg, Courtney D, Bidegain, Margarita
Médium: Artigo
Jazyk:Inglês
Vydáno: 2010
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2972386/
https://ncbi.nlm.nih.gov/pubmed/20671714
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/jp.2010.85
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky